Oral administration of d-serine prevents the onset and progression of colitis in mice
Takehito Asakawa(Yokohama Municipal Minato Red Cross Hospital), Mamoru Watanabe(The University of Tokyo), Takashi Nagaishi(Tokyo Medical and Dental University), Kiichiro Tsuchiya(Tokyo Medical and Dental University), Chikako Saito(Fukushima Medical University), Hiromasa Ohira(Fukushima Medical University), Michio Onizawa(Fukushima Medical University), Daiki Yamada(Tokyo Medical and Dental University), Tomoaki Mochimaru(Fukushima Medical University), Shigeru Oshima(Tokyo Medical and Dental University), Ryuichi Okamoto(Tokyo Medical and Dental University), Shun‐ichiro Asahara(Kobe University), Ai Minamidate(Tokyo Medical and Dental University), Yoshiaki Kido(Kobe University), Rie Hikichi(Fukushima Medical University)
Cited by 23
Related Papers
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
|The Lancet|2021|452
Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo
|Nature Medicine|2004|392
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
|Circulation|2009|358
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272